Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kristin C. Hicks, Massimo Fantini, Renee N. Donahue, Angie Schwab, Karin M. Knudson, Sarah R. Tritsch, Caroline Jochems, Paul E. Clavijo, Clint T. Allen, James W. Hodge, Kwong Y. Tsang, Jeffrey Schlom & Sofia R. Gameiro. (2018) Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. OncoImmunology 7:11.
Read now
Read now
Articles from other publishers (45)
Winston Hibler, Glenn Merlino & Yanlin Yu. (2023) CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects. Cells 12:23, pages 2750.
Crossref
Crossref
Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine Mitsiades & Donald Kufe. (2023) MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. Journal for ImmunoTherapy of Cancer 11:2, pages e006238.
Crossref
Crossref
Elena Obrador, Rosario Salvador-Palmer, Rafael López-Blanch, María Oriol-Caballo, Paz Moreno-Murciano & José M. Estrela. (2023) Survival Mechanisms of Metastatic Melanoma Cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System. Cells 12:3, pages 418.
Crossref
Crossref
Silvia López-Borrego, Carmen Campos-Silva, Amaia Sandúa, Tamara Camino, Lucía Téllez-Pérez, Estibaliz Alegre, Alexandra Beneitez, Ricardo Jara-Acevedo, Annette Paschen, María Pardo, Álvaro González & Mar Valés-Gómez. (2023) MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Carmen Campos-Silva, Yaiza Cáceres-Martell, Estela Sánchez-Herrero, Amaia Sandúa, Alexandra Beneitez-Martínez, Álvaro González, Mariano Provencio, Atocha Romero, Ricardo Jara-Acevedo, María Yáñez-Mó & Mar Valés‐Gómez. (2022) A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Yu-Fan Liu, Yun Chiang, Feng-Ming Hsu, Chiao-Ling Tsai & Jason Chia-Hsien Cheng. (2022) Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Tiancheng Zhang, Chenhao Zhang, Zile Fu & Qiang Gao. (2022) Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy. Pharmaceutics 14:9, pages 1768.
Crossref
Crossref
Adriana Celesia, Antonietta Notaro, Marzia Franzò, Marianna Lauricella, Antonella D’Anneo, Daniela Carlisi, Michela Giuliano & Sonia Emanuele. (2022) The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis. Biomedicines 10:8, pages 1994.
Crossref
Crossref
Chuqiao Wang, Zeqi Wang, Tengteng Yao, Jibo Zhou & Zhaoyang Wang. (2022) The immune-related role of beta-2-microglobulin in melanoma. Frontiers in Oncology 12.
Crossref
Crossref
Anna Lisa Furfaro, Giulia Loi, Caterina Ivaldo, Mario Passalacqua, Gabriella Pietra, Giovanni Enrico Mann & Mariapaola Nitti. (2022) HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia. Antioxidants 11:6, pages 1171.
Crossref
Crossref
Estela Sánchez-Herrero, Carmen Campos-Silva, Yaiza Cáceres-Martell, Lucía Robado de Lope, Sandra Sanz-Moreno, Roberto Serna-Blasco, Alejandro Rodríguez-Festa, Dunixe Ares Trotta, Paloma Martín-Acosta, Cristina Patiño, María José Coronado, Alexandra Beneitez, Ricardo Jara, Nerea Lago-Baameiro, Tamara Camino, Alberto Cruz-Bermúdez, María Pardo, Víctor González-Rumayor, Mar Valés-Gómez, Mariano Provencio & Atocha Romero. (2022)
ALK
-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing
. Clinical Chemistry 68:5, pages 668-679.
Crossref
Crossref
Amber B. Jones, Abbey Rocco, Lawrence S. Lamb, Gregory K. Friedman & Anita B. Hjelmeland. (2022) Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression. Cancers 14:9, pages 2339.
Crossref
Crossref
Meng-Wei Ko, Kawaljit Kaur, Tahmineh Safaei, Wuyang Chen, Christine Sutanto, Paul Wong & Anahid Jewett. (2022) Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes. Cells 11:4, pages 697.
Crossref
Crossref
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, Samira Molaei Ramshe, Leila Asef-Kabiri, Hassan Yousefi, Mohammad Esmaeil Akbari & Nahid Eskandari. (2022) Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Molecular Cancer 21:1.
Crossref
Crossref
Joey H. Li & Timothy E. O’Sullivan. (2022) Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function. Frontiers in Immunology 12.
Crossref
Crossref
Carmen Campos-Silva, Silvia López-Borrego, María José Felgueres, Gloria Esteso & Mar Vales-Gomez. (2022) NKG2D Ligands in Liquid Biopsy: The Importance of Soluble and Vesicle-Bound Proteins for Immune Modulation. Critical Reviews in Immunology 42:1, pages 21-40.
Crossref
Crossref
Luis Sánchez-del-Campo, Román Martí-Díaz, María F. Montenegro, Rebeca González-Guerrero, Trinidad Hernández-Caselles, Enrique Martínez-Barba, Antonio Piñero-Madrona, Juan Cabezas-Herrera, Colin R. Goding & José Neptuno Rodríguez-López. (2021) MITF induces escape from innate immunity in melanoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Amanda A. van Vliet, Anna-Maria Georgoudaki, Monica Raimo, Tanja D. de Gruijl & Jan Spanholtz. (2021) Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma. Cancers 13:18, pages 4722.
Crossref
Crossref
Mercedes Beatriz Fuertes, Carolina Inés Domaica & Norberto Walter Zwirner. (2021) Leveraging NKG2D Ligands in Immuno-Oncology. Frontiers in Immunology 12.
Crossref
Crossref
Fabrizio Marcucci & Cristiano Rumio. (2021) Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer. Cells 10:4, pages 872.
Crossref
Crossref
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2021) Immunomodulation by targeted anticancer agents. Cancer Cell 39:3, pages 310-345.
Crossref
Crossref
Elisa C. Toffoli, Abdolkarim Sheikhi, Yannick D. Höppner, Pita de Kok, Mahsa Yazdanpanah-Samani, Jan Spanholtz, Henk M. W. Verheul, Hans J. van der Vliet & Tanja D. de Gruijl. (2021) Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response. Cancers 13:4, pages 711.
Crossref
Crossref
Baokai Dou, Shichun Li, Luyao Wei, Lixin Wang, Shiguo Zhu, Zhengtao Wang, Zunji Ke, Kaixian Chen & Zhifei Wang. (2020) Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition. Frontiers of Medicine 15:1, pages 79-90.
Crossref
Crossref
Kawaljit Kaur, Tahmineh Safaie, Meng-Wei Ko, Yuhao Wang & Anahid Jewett. (2021) ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor. Cancers 13:2, pages 239.
Crossref
Crossref
Carmen Campos-Silva, Yaiza Cáceres-Martell, Sheila López-Cobo, María Josefa Rodriguez, Ricardo Jara, María Yáñez-Mó & Mar Valés-Gómez. 2021. Melanoma. Melanoma
323
344
.
Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, Gianluigi Ferretti, Francesco Cognetti, Ludovica Ciuffreda & Michele Milella. (2020) Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy. Cancers 12:10, pages 2870.
Crossref
Crossref
Minjeong Yeon, Youngmi Kim, Hyun Suk Jung & Dooil Jeoung. (2020) Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
John M. Idso, Shunhua Lao, Nathan J. Schloemer, Jeffrey Knipstein, Robert Burns, Monica S. Thakar & Subramaniam Malarkannan. (2020) Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway. Oncotarget 11:20, pages 1799-1815.
Crossref
Crossref
Chongren Ren, Xiaojing Ren, Dujuan Cao, Haichao Zhao, Zhensheng Zhai, Huiyu Li, Yanjun Li, Xifeng Fu, Jiefeng He & Haoliang Zhao. (2020) CNOT7 depletion reverses natural killer cell resistance by modulating the tumor immune microenvironment of hepatocellular carcinoma. FEBS Open Bio 10:5, pages 847-860.
Crossref
Crossref
Anna L. Furfaro, Selene Ottonello, Giulia Loi, Irene Cossu, Sabrina Piras, Francesco Spagnolo, Paola Queirolo, Umberto M. Marinari, Lorenzo Moretta, Maria A. Pronzato, Maria C. Mingari, Gabriella Pietra & Mariapaola Nitti. (2019)
HO‐1 downregulation favors BRAF
V600
melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition
. International Journal of Cancer 146:7, pages 1950-1962.
Crossref
Crossref
Laura Damele, Selene Ottonello, Maria Cristina Mingari, Gabriella Pietra & Chiara Vitale. (2020) Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?. Cancers 12:4, pages 774.
Crossref
Crossref
Anahid Jewett, Janko Kos, Kawaljit Kaur, Tahmineh Safaei, Christine Sutanto, Wuyang Chen, Paul Wong, Artin Keshishian Namagerdi, Changge Fang, Yuman Fong & Meng-Wei Ko. (2020) Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis. Molecular Therapy - Oncolytics 16, pages 41-52.
Crossref
Crossref
Lydia Bellmann, Giuseppe Cappellano, Johanna F. Schachtl‐Riess, Anastasia Prokopi, Athanasios Seretis, Daniela Ortner, Christoph H. Tripp, Constance E. Brinckerhoff, David W. Mullins & Patrizia Stoitzner. (2019) A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model. International Journal of Cancer 146:5, pages 1409-1420.
Crossref
Crossref
Monica Marzagalli, Nancy D. Ebelt & Edwin R. Manuel. (2019) Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Seminars in Cancer Biology 59, pages 236-250.
Crossref
Crossref
Michael Schnekenburger, Mario Dicato & Marc F. Diederich. (2019) Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?. Cancer 125:10, pages 1612-1628.
Crossref
Crossref
Alexandra Frazao, Louise Rethacker, Meriem Messaoudene, Marie-Françoise Avril, Antoine Toubert, Nicolas Dulphy & Anne Caignard. (2019) NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment. Frontiers in Immunology 10.
Crossref
Crossref
Iris Helfrich & Bernhard Singer. (2019) Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in Melanoma. Cancers 11:3, pages 356.
Crossref
Crossref
Carmen Campos-Silva, Henar Suárez, Ricardo Jara-Acevedo, Estefanía Linares-Espinós, Luis Martinez-Piñeiro, María Yáñez-Mó & Mar Valés-Gómez. (2019) High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry. Scientific Reports 9:1.
Crossref
Crossref
Paola Kučan Brlić, Tihana Lenac Roviš, Guy Cinamon, Pini Tsukerman, Ofer Mandelboim & Stipan Jonjić. (2018) Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cellular & Molecular Immunology 16:1, pages 40-52.
Crossref
Crossref
Sheila López-Cobo, Carmen Campos-Silva, Amanda Moyano, Myriam Oliveira-Rodríguez, Annette Paschen, María Yáñez-Mó, María Carmen Blanco-López & Mar Valés-Gómez. (2018) Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma. Journal of Nanobiotechnology 16:1.
Crossref
Crossref
Anahid Jewett, Janko Kos, Yuman Fong, Meng-Wei Ko, Tahmineh Safaei, Milica Perišić Nanut & Kawaljit Kaur. (2018) NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis. Seminars in Cancer Biology 53, pages 178-188.
Crossref
Crossref
Eszter Lajkó, Sarah Spring, Rózsa Hegedüs, Beáta Biri-Kovács, Sven Ingebrandt, Gábor Mező & László Kőhidai. (2018) Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids. Beilstein Journal of Organic Chemistry 14, pages 2495-2509.
Crossref
Crossref
Dominik Schmiedel & Ofer Mandelboim. (2018) NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy. Frontiers in Immunology 9.
Crossref
Crossref
C. Campos‐Silva, M. K. Kramer & M. Valés‐Gómez. (2018) NKG2D‐ligands: Putting everything under the same umbrella can be misleading. HLA 91:6, pages 489-500.
Crossref
Crossref
Kawaljit Kaur, Milica Perišić Nanut, Meng-Wei Ko, Tahmineh Safaie, Janko Kos & Anahid Jewett. (2018) Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy. Current Opinion in Immunology 51, pages 170-180.
Crossref
Crossref